DUOPHARM
De berekende faillissementskans van DUOPHARM over 12 maanden bedraagt 0,4% (zeer laag). Het bedrijf is actief sinds 1977 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 48 jaar |
| Vestigingen | 1 |
| Publicaties | 1 |
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 30-06-2024 | verkort | 02-01-2025 | 2025-00630892 |
| 30-06-2023 | verkort | 29-01-2024 | 2024-00025629 |
| 30-06-2022 | verkort | 23-12-2022 | 2022-20548276 |
| 30-06-2021 | verkort | 31-01-2022 | 2022-04600275 |
| 30-06-2020 | verkort | 27-01-2021 | 2021-04600127 |
| 30-06-2019 | verkort | 23-01-2020 | 2020-02300328 |
| 30-06-2018 | verkort | 19-12-2018 | 2018-75800138 |
| 30-06-2017 | verkort | 30-01-2018 | 2018-03900349 |
| 30-06-2016 | verkort | 30-01-2017 | 2017-03600521 |
| 30-06-2015 | verkort | 04-01-2016 | 2016-00100525 |
| NACE primair | Detailhandel(47730) |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 15-12-1977 |
| Status | Actief |
| Postcode | 9280 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 42011B0219/00K000 | Vlaanderen | 486 m² | 1 · 293 m² | 12,4 m · 2 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
26-02-2025 Kapitaalverhoging van €62.000 tot €124.000
- €62.000 → €124.000
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 124000.0,
"delta_eur": 62000.0,
"before_eur": 62000.0,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 750,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 750,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": "0473.221.626",
"rrn": null,
"kind": "org",
"name": "K\u0026G",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": 748,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 748,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "BAUWENS Greet",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": 1,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 1,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "HULPIAU Kristel",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": 1,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 1,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Sylvie Sergeant",
"firm_city": null,
"firm_name": null,
"office_city": "Zele",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-02-26",
"filing_date": "2025-02-18",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-01-29",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "BV BEDRIJFSREVISOR BART BOSMAN",
"ibr_number": null,
"mission_type": "quasi_apport",
"individual_name": "Bart Bosman"
},
"subject_company": {
"kbo": "0417.916.679",
"name_full": "DUOPHARM",
"legal_form": "Naamloze Vennootshcap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"plan financier",
"bankattest",
"verslag bedrijfsrevisor"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "BAUWENS Greet",
"role": null,
"n_shares": 1,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "HULPIAU Kristel",
"role": null,
"n_shares": 1,
"share_class": null
},
{
"kbo": "0473.221.626",
"pct": null,
"kind": "org",
"name": "K\u0026G",
"role": null,
"n_shares": 748,
"share_class": null
}
],
"share_classes_after": []
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamNL | DUOPHARM |